Balentine LLC’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,246
| Closed | -$310K | – | 426 |
|
|
2024
Q1 | $310K | Sell |
2,246
-70
| -3% | -$9.65K | 0.01% | 391 |
|
|
2023
Q4 | $305K | Buy |
2,316
+89
| +4% | +$11.7K | 0.01% | 385 |
|
|
2023
Q3 | $251K | Buy |
+2,227
| New | +$251K | 0.01% | 409 |
|
|
2020
Q3 | – | Sell |
-9
| Closed | -$1K | – | 610 |
|
|
2020
Q2 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 907 |
|
|
2019
Q3 | – | Sell |
-15
| Closed | -$1K | – | 791 |
|
|
2019
Q2 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 720 |
|